Subcutaneous versus intravenous trastuzumab in early breast cancer: 2-year follow-up of HannaH

被引：0
|
作者：
Jackisch, C. [1 ,2 ]
Hegg, R. [3 ]
Stroyakovskiy, D. [4 ]
Ahn, J. [5 ]
Melichar, B. [6 ,7 ]
Chen, S. C. [8 ]
Crepelle-Flechais, A. [9 ]
Heinzmann, D. [10 ]
Shing, M. [11 ]
Pivot, X. [12 ]
机构：
[1] Sana Klinikum Offenbach GmbH, Dept Obstet & Gynecol, Offenbach, Germany
[2] Sana Klinikum Offenbach GmbH, Breast Canc & Gynecol Canc Ctr, Offenbach, Germany
[3] Hosp Perola Byington, Dept Gynecol & Obstet, Sao Paulo, Brazil
[4] City Clin Oncol Hosp 62, Chemotherapeut Dept, Moscow, Russia
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea
[6] Palacky Univ, Sch Med, Dept Oncol, CR-77147 Olomouc, Czech Republic
[7] Teaching Hosp, Olomouc, Czech Republic
[8] Chang Gung Mem Hosp, Dept Surg, Taipei 10591, Taiwan
[9] F Hoffmann La Roche Ltd, Global Pharma Dev, Basel, Switzerland
[10] F Hoffmann La Roche Ltd, Biostat, Basel, Switzerland
[11] Genentech Inc, Global Pharma Dev, San Francisco, CA 94080 USA
[12] CHU Jean Minjoz, Chemotherapy Oncol, Besancon, France
来源：
BREAST | 2015年 / 24卷
关键词：
D O I：
10.1016/S0960-9776(15)70235-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P201
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [1] Intravenous versus subcutaneous trastuzumab in the treatment of breast cancer
    Maximiano, S.
    Magalhaes, P.
    Pereira Guerreiro, M.
    Morgado, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 597 - 597
  • [2] Neurocognition in early psychosis: A 2-year follow-up
    Addington, J
    Addington, DE
    Hutchinson, JE
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 128 - 128
  • [3] Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients' With HER2-Positive Metastatic Breast Cancer
    Pivot, Xavier
    Spano, Jean-Philippe
    Espie, Marc
    Jouannaud, Christelle
    Pottier, Valerie
    Moreau, Laura
    Extra, Jean Marc
    Lortholary, Alain
    Rivera, Pascale
    Spaeth, Dominique
    Mouri, Zahira
    Tariket, Fella
    Dupin, Julien
    Berthois, Aurelien
    Ionescu-Goga, Miruna
    Ferhat, Abdennour
    Cottu, Paul
    Gligorov, Joseph
    CLINICAL BREAST CANCER, 2023, 23 (07) : e412 - e419
  • [4] Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study
    Jackisch, C.
    Kim, S. -B.
    Semiglazov, V.
    Melichar, B.
    Pivot, X.
    Hillenbach, C.
    Stroyakovskiy, D.
    Lum, B. L.
    Elliott, R.
    Weber, H. A.
    Ismael, G.
    ANNALS OF ONCOLOGY, 2015, 26 (02) : 320 - 325
  • [5] 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
    Smith, Ian
    Procter, Marion
    D Gelber, Richard
    Guillaume, Sebastien
    Feyereislova, Andrea
    Dowsett, Mitch
    Goldhirsch, Aron
    Untch, Michael
    Mariani, Gabriella
    Baselga, Jose
    Kaufmann, Manfred
    Cameron, David
    Bell, Richard
    Bergh, Jonas
    Coleman, Robert
    Wardley, Andrew
    Harbeck, Nadia
    Lopez, Roberto I.
    Mallmann, Peter
    Gelmon, Karen
    Wilcken, Nicholas
    Wist, Erik
    Sanchez Rovira, Pedro
    Piccart-Gebhart, Martine
    LANCET, 2007, 369 (9555): : 29 - 36
  • [6] EARLY INTERVENTION WITH PORTUGUESE MOTHERS - A 2-YEAR FOLLOW-UP
    GOMESPEDRO, J
    PATRICIO, M
    CARVALHO, A
    GOLDSCHMIDT, T
    TORGALGARCIA, F
    MONTEIRO, MB
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 1995, 16 (01): : 21 - 28
  • [7] MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer: 2-Year Follow-up
    Debruhl, Nanette D.
    Lee, Su-Ju
    Mahoney, Mary C.
    Hanna, Lucy
    Tuite, Catherine
    Gatsonis, Constantine A.
    Lehman, Constance
    JOURNAL OF BREAST IMAGING, 2020, 2 (01) : 50 - 55
  • [8] TVT versus TOT at 2-year follow-up:: Results and complications
    Weemhoff, M.
    Bremer, H. A.
    Kampschoer, P. H. N. M.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2007, 18 : S214 - S215
  • [9] Does early detection reduce suicidality? A 2-year follow-up
    Haahr, U.
    Melle, I.
    Larsen, T. K.
    Friis, S.
    Johannesen, J. O.
    Opjordsmoen, S. I.
    Rund, B. R.
    Simonsen, E.
    Vaglum, P.
    McGlashan, Th. H.
    SCHIZOPHRENIA RESEARCH, 2006, 86 : S24 - S24
  • [10] Does early detection improve outcome? A 2-year follow-up
    Melle, I.
    Larsen, T. K.
    Haahr, U.
    Friis, S.
    Johannesen, J. O.
    Opjordsmoen, S. I.
    Rund, B. R.
    Simonsen, E.
    Vaglum, P.
    McGlashan, Th. H.
    SCHIZOPHRENIA RESEARCH, 2006, 86 : S24 - S24
12345